Posted on January 31, 2017
After completing his BS in Biology at UNCG in 1998, David returned to UNCG to pursue his master’s degree in Biology under the direction of Dr. Esther Leise. His master’s thesis was titled “Programmed Cell Death during the Metamorphosis of Ilyanassa obsoleta.” After his master’s degree, David pursued his doctoral degree in the Program in Neuroscience at the Wake Forest University School of Medicine. His dissertation research was focused on a mouse model for Lou Gehrig’s Disease. While a postdoctoral research fellow in the Department of Neurobiology and Anatomy at Wake Forest University School of Medicine, David worked as a lecturer for our Biology Department teaching cell biology and introductory biology labs . Currently, David is a postdoctoral research scientist at Eli Lilly and Company in Indianapolis, Indiana. He is pursuing research in muscle atrophy to identify novel targets relevant to human diseases, and performing research to explore the integration of muscle, bone, and/or cartilage molecular pathways as they relate to mobility impairments.